In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
ArriVent BioPharma Inc (NASDAQ: AVBP) closed the day trading at $18.93 down -3.07% from the previous closing price of $19.53. In other words, the price has decreased by -$3.07 from its previous closing price. On the day, 0.7 million shares were traded. AVBP stock price reached its highest trading level at $19.855 during the session, while it also had its lowest trading level at $18.4.
Ratios:
For a better understanding of AVBP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.90 and its Current Ratio is at 14.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on December 10, 2025, initiated with a Buy rating and assigned the stock a target price of $45.
On November 25, 2025, Truist started tracking the stock assigning a Buy rating and target price of $43.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVBP now has a Market Capitalization of 781456128 and an Enterprise Value of 481246176.
Stock Price History:
The Beta on a monthly basis for AVBP is 1.05, which has changed by -0.27289653 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, AVBP has reached a high of $29.71, while it has fallen to a 52-week low of $15.47. The 50-Day Moving Average of the stock is -10.32%, while the 200-Day Moving Average is calculated to be -6.96%.
Shares Statistics:
Over the past 3-months, AVBP traded about 376.58K shares per day on average, while over the past 10 days, AVBP traded about 437520 shares per day. A total of 40.85M shares are outstanding, with a floating share count of 26.30M. Insiders hold about 36.30% of the company’s shares, while institutions hold 70.50% stake in the company. Shares short for AVBP as of 1765756800 were 6747370 with a Short Ratio of 17.92, compared to 1763078400 on 7169047. Therefore, it implies a Short% of Shares Outstanding of 6747370 and a Short% of Float of 21.72.
Earnings Estimates
The firm’s stock currently is rated by 11.0 analysts. The consensus estimate for the next quarter is -$0.92, with high estimates of -$0.77 and low estimates of -$1.05.
Analysts are recommending an EPS of between -$2.96 and -$4.82 for the fiscal current year, implying an average EPS of -$4.29. EPS for the following year is -$3.91, with 11.0 analysts recommending between -$3.12 and -$5.25.
